ABT-122
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ABT-122, covering 2016-06-17 to 2017-11-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis [Phase 1]